Worth reading
66In focus
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
686000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数686,000Shares
686,000 shares (new shares); no treasury shares transferred
発行済株式総数
0.95% (exercise ratio relating to the exercise restrictions; the ratio of shares exercised in this period to total shares outstanding is not disclosed)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥132–¥139 per share. Details of the adjustment provisions and the adjustment floor are not disclosed
Number of Stock Acquisition Rights
Approximately 370,810 rights in total (an estimate calculated from the statement that 6,860 rights represented 1.85% of the total issued rights; the document does not disclose the actual total). 282,610 rights remained unexercised at the end of the preceding month, and 275,750 rights remained unexercised at the end of the relevant month
Procedures under the Corporate Code of Conduct
Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
The 22nd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued on 30 October 2025, Determination of the issue terms and other conditions for the Series 22 Stock Acquisition Rights through a third-party allotment, dated 15 October 2025
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly report on the exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | 686,000 shares (new shares); no treasury shares transferred |
| Dilution Rate | 0.95% (exercise ratio relating to the exercise restrictions; the ratio of shares exercised in this period to total shares outstanding is not disclosed) |
| Total number of issued shares | 82,100,758 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | ¥132–¥139 per share. Details of the adjustment provisions and the adjustment floor are not disclosed |
| Number of Stock Acquisition Rights | Approximately 370,810 rights in total (an estimate calculated from the statement that 6,860 rights represented 1.85% of the total issued rights; the document does not disclose the actual total). 282,610 rights remained unexercised at the end of the preceding month, and 275,750 rights remained unexercised at the end of the relevant month |
| Procedures under the Corporate Code of Conduct | Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | The 22nd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued on 30 October 2025, Determination of the issue terms and other conditions for the Series 22 Stock Acquisition Rights through a third-party allotment, dated 15 October 2025 |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in April 2026 of the Series 22 Stock Acquisition Rights issued on 30 October 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.